Search
for
Sort by
Research 571–600 of 638
- Diffuser Haarausfall und klinische Endokrinologie: Neue Erkenntnisse
- The patient outcomes with EGFR-mutated advanced non-small-cell lung cancer receiving aumolertinib as first-line treatment.
- 1272 p21Waf1/Cip1 is differentially expressed in epidermal versus follicular melanocytes and melanoma cells and is phenotypically regulated by UVB-mediated apoptosis
- Inositol and FSH: A new frontier for the androgenetic alopecia treatment in PCOS
- Metabolic effects of duodenal mucosal resurfacing on insulin resistant women with polycystic ovary syndrome
- Trichoscopy in alopecias: Diagnosis simplified
- The Lipid Profiles in Different Characteristics of Women with PCOS and the Interaction Between Dyslipidemia and Metabolic Disorder States: A Retrospective Study in Chinese Population
- Follicular-targeted delivery of spironolactone provided by polymeric nanoparticles
- Acne - a potential skin marker of internal disease
- Advancing mitochondrial therapeutics: Synthesis and pharmacological evaluation of pyrazole-based inhibitors targeting the mitochondrial pyruvate carrier
- Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study
- Coreopsis tinctoria Nutt. As a New Raw Material for Natural Hair Coloration: Discovering the Dyeing Potential of Chalcones
- Pediatric Hair Cosmetics: Physiology, Safety and Product Considerations
- Assessment of adipokines, hormonal profile, lipid profile, and insulin resistance in patients with androgenetic alopecia
- Comparison of the Effect of Auriculotherapy, a Herbal Compound (Aslagh Capsule), and Metformin on the Clinical Symptoms of Polycystic Ovary Syndrome: Randomized Clinical Trial
- Diphenyl cresyl phosphate [MAK Value Documentations, 2003]
- Teledermatology Service During the COVID-19 Pandemic in China: A Mobile Application-Based Retrospective Study
- Global Impact of Coronavirus Disease 2019 (COVID-19)
- Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality
- Metabolic Syndrome and Skin Diseases
- Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata – part II
- Hair Growth Cycle Is Arrested in SCD1 Deficiency by Impaired Wnt3a-Palmitoleoylation and Retrieved by the Artificial Lipid Barrier
- Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
- The Effect of a Very-Low-Calorie Diet (VLCD) vs. a Moderate Energy Deficit Diet in Obese Women with Polycystic Ovary Syndrome (PCOS)—A Randomised Controlled Trial
- Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones
- Implication of Human Bacterial Gut Microbiota on Immune-Mediated and Autoimmune Dermatological Diseases and Their Comorbidities: A Narrative Review
- Association of hair dye use with circulating levels of sex hormones in premenopausal Japanese women
- PCOS in Adolescents—Ongoing Riddles in Diagnosis and Treatment
- The Relation of Androgenetic Alopecia Severity with Epicardial Fat Thickness
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)